Results 31 to 40 of about 29,787,584 (247)

Development and validation of grade‐based prediction models for postoperative morbidity in gastric cancer resection using a Japanese web‐based nationwide registry

Annals of Gastroenterological Surgery, 2019
Aim Gastric cancer is the second leading cause of cancer death worldwide. Surgery is the mainstay treatment for gastric cancer. There are no prediction models that examine the severity of postoperative morbidity.
Yoshio Haga, Hiroaki Miyata, Akira Tsuburaya, Mitsukazu Gotoh, Kazuhiro Yoshida, Hiroyuki Konno, Yasuyuki Seto, Yoshiyuki Fujiwara, Hideo Baba   +8 more
doaj   +1 more source

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin, Sheila K. Pierson, Kelley C. Dacus, Mateo Sarmiento Bustamante, Saishravan Shyamsundar, Larissa Borys, Kayla McHugh, Abiola Irvine, Yoojin Jo, Adam Bagg, Mary Jo Lechowicz, Daisy Alapat, Amy Chadburn, Megan S. Lim, Gordan Srkalovic, Frits van Rhee, David C. Fajgenbaum, Joshua D. Brandstadter   +17 more
wiley   +1 more source

Irish Hip Fracture Database National Report 2016 [PDF]

, 2017
Welcome to the Irish Hip Fracture Database (IHFD) National Report 2016. This fourth IHFD report details 3,159 hip fracture cases in patients aged 60 years and over, discharged by 16 hospitals in 2016, which accounts for 86% of all hip fracture cases ...
National Office of Clinical Audit
core  

Stop Smoking: National Clinical Guideline No. 28

, 2022
This National Clinical Guideline has been developed by the Stop Smoking Guideline Development Group (GDG), within the Tobacco Free Ireland Programme, Strategy & Research, Healthcare Strategy, Health Service Executive (HSE).
Department of Health (DoH), National Clinical Effectiveness Committee (NCEC)   +1 more
core  

Frequency and risk factors for venous thromboembolism after gastroenterological surgery based on the Japanese National Clinical Database (516 217 cases)

Annals of Gastroenterological Surgery, 2019
Aim To investigate the frequency and risk factors of perioperative, symptomatic venous thromboembolism (VTE) after gastroenterological surgery. Methods We assessed the frequency of and risk factors for VTE after eight gastroenterological procedures ...
Taishi Hata, Masataka Ikeda, Hiroaki Miyata, Masatoshi Nomura, Mitsukazu Gotoh, Masato Sakon, Kouji Yamamoto, Go Wakabayashi, Yasuyuki Seto, Masaki Mori, Yuichiro Doki   +10 more
doaj   +1 more source

The Impact of the COVID‐19 Pandemic on Childhood Cancer Survival: A Population‐Based Assessment of Survival Patterns Between 2015 and 2023 in Germany

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Numerous international studies have reported declines in new cancer diagnoses, delayed diagnoses and disruptions in cancer treatment following the implementation of COVID‐19 pandemic public health measures, raising concerns that these effects may ultimately contribute to increased cancer mortality.
Friederike Erdmann, Maike Wellbrock, Javier Louro, Arndt Borkhardt, Martin Schrappe, Claudia Trübenbach, Desiree Grabow, Cécile M. Ronckers, Joachim Schüz   +8 more
wiley   +1 more source

Investigation of the impact of COVID‐19 on postoperative outcomes using a nationwide Japanese database of patients undergoing laparoscopic distal gastrectomy and low anterior resection for gastric cancer and rectal cancer

Annals of Gastroenterological Surgery
Background The COVID‐19 outbreak made conventional medical care impossible, forcing changes in both healthcare providers and patients. In Japan, COVID‐19 infection began spreading in earnest in 2020 and exploded in 2021.
Tomonori Akagi, Hideki Endo, Masafumi Inomata, Hidefumi Shiroshita, Shigeki Yamaguchi, Susumu Eguchi, Norihito Wada, Yukinori Kurokawa, Yosuke Seki, Yoshiharu Sakai, Hiroyuki Yamamoto, Yoshihiro Kakeji, Yuko Kitagawa, Akinobu Taketomi, Masaki Mori   +14 more
doaj   +1 more source

Clinical outcomes of de novo metastatic HER2-low breast cancer: a National Cancer Database Analysis

npj Breast Cancer, 2022
The development of novel anti-HER2 drugs opens new treatment options for women with breast cancers, including lower expression of HER2. The epidemiology and clinical outcome of metastatic HER2-low breast cancer remain not well described.
Changchuan Jiang, Stuthi Perimbeti, Lei Deng, Charles L. Shapiro, Shipra Gandhi   +4 more
doaj   +1 more source

Establishing an Apheresis Medicine Program in a Resource‐Constrained Setting: A 5‐Year Experience From Lagos, Nigeria

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Establishing a comprehensive apheresis medicine program in a resource‐constrained setting presents significant structural, financial, and logistical challenges. Despite the growing clinical importance of apheresis services globally, published experience from sub‐Saharan Africa remains sparse.
Folasade Adelekan‐Popoola, Shakirat Gold‐Olufadi, Olufunto Olufela Kalejaiye, Abdullateef Ogala, Rasheed A. Balogun   +4 more
wiley   +1 more source

Unexpected Intraoperative Life Threatening Haemorrhage: National Clinical Guideline No. 29: Annex A: Clinical Guidelines for the Management of Massive Haemorrhage – A systematic review. [PDF]

, 2020
In 2016, the Department of Health requested that the Health Research Board (HRB) fund an evidence synthesis service called HRB-CICER (Collaboration in Ireland for Clinical Effectiveness Reviews) to support the activities of the Ministerial appointed ...
National Clinical Effectiveness Committee (NCEC), National Patient Safety Office, Health Service Executive   +2 more
core